Reference is made to the retail offering (the "Retail Offering") announced by Oncoinvent ASA on 22 September 2026. Please see the attached PDMR-form related to allocation of shares to a primary insider in the Retail Offering.
This information is published in accordance with article 19 of the EU Market Abuse Regulation (MAR).
For further information, please contact:
Oystein Soug, Chief Executive Officer
Email: IR@oncoinvent.com